Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany
Condition(s):Relapsing-Remitting Multiple SclerosisLast Updated:April 18, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Relapsing-Remitting Multiple SclerosisLast Updated:April 18, 2017Completed
Condition(s):ArthritisLast Updated:August 8, 2017Completed
Condition(s):Eosinophilic Gastritis; Eosinophilic GastroenteritisLast Updated:February 20, 2024Completed
Condition(s):AsthmaLast Updated:March 30, 2023Completed
Condition(s):Pneumococcal InfectionsLast Updated:January 25, 2013Completed
Condition(s):TuberculosisLast Updated:February 12, 2024Recruiting
Condition(s):Branchial Plexus Blockade; AnesthesiaLast Updated:March 28, 2022Unknown status
Condition(s):TuberculosisLast Updated:February 8, 2024Recruiting
Condition(s):Rupture of Anterior Cruciate Ligament; Infiltration; Regional Anesthesia MorbidityLast Updated:May 7, 2018Completed
Condition(s):ObesityLast Updated:August 21, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.